Secondly, they showed that about one-half of non-invasive tumours show high-grade histology and HER2 3+ protein expression on immunohistochemistry, therefore paving the way for HER2 gene amplification by fluorescent in situ hybridisation in all HER2 3+ high-grade NMIBC. Here, ERBB2 is linked to neoplasm.